ENHANCED EXPRESSION OF NEUTRAL ENDOPEPTIDASE (NEP) IN AIRWAY EPITHELIUM IN BIOPSIES FROM STEROID-TREATED VERSUS NONSTEROID-TREATED PATIENTSWITH ATOPIC ASTHMA
Jk. Sont et al., ENHANCED EXPRESSION OF NEUTRAL ENDOPEPTIDASE (NEP) IN AIRWAY EPITHELIUM IN BIOPSIES FROM STEROID-TREATED VERSUS NONSTEROID-TREATED PATIENTSWITH ATOPIC ASTHMA, American journal of respiratory cell and molecular biology, 16(5), 1997, pp. 549-556
The expression of the endogenous neuropeptide-degrading enzyme, neutra
l endopeptidase (NEP; CALLA, CD10, E.C.3.4.24.11) on cultured human ai
rway epithelial cells can be upregulated by corticosteroids. We examin
ed whether NEP expression in the airway epithelium or lamina propria i
n bronchial biopsies is enhanced in atopic asthmatics on regular inhal
ed steroids as compared with those without steroid treatment. Forty no
nsmoking adults (age 19 to 48 yr) with mild to moderate asthma (forced
expiratory volume in 1 s greater than or equal to 50 % pred., histami
ne PC20 range 0.02 to 7.6 mg/ml) with (n = 23) or without (n = 17) reg
ular inhaled steroids treatment entered the study. Biopsies were taken
at (sub)segmental level from the right lower lobe, the middle lobe, a
nd the main carina. Immunohistochemical staining was performed on cryo
stat sections using the VIL-A1 monoclonal antibody against CD10 (NEP).
Intra- and inter-observer repeatability of a semiquantitative scoring
method was good as assessed by weighted kappa (kappa(w) ranging from
0.66 to 0.81). In the airway epithelium, NEP-positive sites were withi
n the basal layer and, in contrast with studies applying other antibod
ies, also at apical sites and within the lamina propria. In both the e
pithelium and lamina propria, NEP expression was not significantly dif
ferent between the three biopsy sites (Friedman's nonparametric two-wa
y analysis of variance; P > 0.68), nor was expression in the lamina pr
opria associated with inhaled steroid usage (Mann-Whitney U test; P =
0.98). However, NEP expression was significantly enhanced in the airwa
y epithelium in patients using inhaled steroids as compared with nonst
eroid users (mean rank: 23.4 and 15.5, respectively; P = 0.02). Among
nonsteroid-using subjects, NEP expression was related to symptoms and
the methacholine PC20 (R-s: -0.69 and 0.49, respectively; P less than
or equal to 0.04). We conclude that the expression of NEP is enhanced
in airway epithelium in bronchial biopsy specimens from patients with
atopic asthma who are regularly using inhaled steroids as compared wit
h patients who do not. This fits the hypothesis that the anti-inflamma
tory effect of corticosteroids within the airways is partially mediate
d by the upregulation of the endogenous neuropeptide-degrading enzyme
NEP.